Compensation and Governance Committee
(view the charter) - determines the compensation of executive officers and recommends to the Board of Directors the compensation of outside directors, exercises authority of the Board of Directors concerning employee benefit plans and advises the Board of Directors on other compensation and employee benefit matters. The Compensation Committee advises the Board of Directors on board committee structure and membership and corporate governance matters. In addition, the Compensation Committee makes recommendations to the Board of Directors regarding candidates for election as directors of the Company and is otherwise responsible for matters relating to the nomination of directors.
William J. Link, Ph.D., age 67. Dr. Link has been a director of the Company since May 2009. He is Managing Director and co-founder of Versant Ventures, a venture capital firm investing in early stage healthcare companies. Prior to co-founding Versant Ventures in 1999, Dr. Link was a general partner at Brentwood Venture Capital. From 1986 to 1997, Dr. Link was founder, Chairman and Chief Executive Officer of Chiron Vision, which was later sold to Bausch & Lomb, Inc. He also founded and served as President of American Medical Optics, Inc., which was acquired by Allergan, Inc. Dr. Link served as a director of Advanced Medical Optics, Inc., from 2002 to 2009. Before entering the healthcare industry, Dr. Link was an assistant professor in the Department of Surgery at the Indiana University School of Medicine. Dr. Link earned his Bachelor's, Master's, and Doctorate degrees in Mechanical Engineering from Purdue University.
Steven R. Loranger, age 64. Mr. Loranger has been a director of the Company since March 2016. He was most recently chief executive officer and president of Xylem Inc., a leading global water technology company, following his service as chairman, president and chief executive officer of ITT Corporation for seven years. Prior to joining ITT, Mr. Loranger served as executive vice president and chief operating officer of Textron, Inc., and held executive positions at Honeywell International Inc. and its predecessor company, AlliedSignal, Inc. Mr. Loranger is a seasoned executive with global experience in highly regulated, high-tech industries. His decades of experience leading large, innovation-focused corporations will be particularly valuable to the Board. He currently serves on the boards of directors of Xylem Inc., the Smithsonian National Air and Space Museum and the Congressional Medal of Honor Foundation. He also served on the board of FedEx Corporation from 2006 to 2014. A former U.S. Navy lieutenant, Mr. Loranger holds bachelor's and master's degrees from the University of Colorado.
Martha H. Marsh, age 67. Ms. Marsh has been a director of the Company since October 2015. She retired in 2010 as President & Chief Executive Officer of Stanford Hospital & Clinics, a position she had held since 2002. She also served as the Chief Executive Officer of the University of California Davis Medical Center from 1999 to 2002. After beginning her career at Arthur Andersen in 1975, she has served the healthcare industry for more than thirty years in a variety of leadership positions including as Senior Vice President for Professional Services and Managed Care at the University of Pennsylvania Health System. Ms. Marsh also served on a variety of healthcare boards and committees. She currently serves on the boards of AMN Healthcare Services, Inc. and Owens & Minor Inc. Ms. Marsh earned a Master of Public Health in health administration and an MBA in accounting from Columbia University. She received her Bachelor’s degree in history at University of Rochester.
Nicholas J. Valeriani, age 58. Mr. Valeriani has been a director of the Company since November 2014 and is a member of the Compensation and Governance Committee of the Board. Since 2012, he has been the Chief Executive Officer of the Gary and Mary West Health Institute, an independent, nonprofit medical research organization that works to create new, more effective ways of delivering care at lower costs. Prior to joining West Health, Mr. Valeriani spent 34 years at Johnson & Johnson and served as a member of its executive committee. He was Company Group Chairman, Ortho-Clinical Diagnostics from 2009-2012, and Vice President, Office of Strategy and Growth from 2007 to 2009. Previously, he held various other key positions at Johnson & Johnson, including Worldwide Chairman, Medical Devices and Diagnostics, and Corporate Vice President, Human Resources. Mr. Valeriani has a bachelor's degree in industrial engineering and an MBA from Rutgers University.
David K. Erickson
Vice President, Investor Relations
phone: (949) 250-6826
Sr. Manager, Investor Relations
phone: (949) 250-2752